StockNews.com Initiates Coverage on Cyclacel Pharmaceuticals (NASDAQ:CYCC)
Investment analysts at StockNews.com started coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a report released on Saturday. The firm set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Down 15.3 % NASDAQ:CYCC opened at $0.25 on Friday. The stock’s 50-day moving average is $0.27 and its 200-day […]
Investment analysts at StockNews.com started coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Free Report) in a report released on Saturday. The firm set a “sell” rating on the biotechnology company’s stock. Cyclacel Pharmaceuticals Trading Down 15.3 % NASDAQ:CYCC opened at $0.25 on Friday. The stock’s 50-day moving average is $0.27 and its 200-day […]
